Krilogy Financial’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,678
Closed -$187K 695
2018
Q1
$187K Hold
1,678
0.04% 163
2017
Q4
$173K Sell
1,678
-1,811
-52% -$180K 0.04% 162
2017
Q3
$329K Hold
3,489
0.08% 106
2017
Q2
$272K Buy
3,489
+1,400
+67% +$105K 0.08% 107
2017
Q1
$165K Hold
2,089
0.05% 149
2016
Q4
$165K Hold
2,089
0.05% 149
2016
Q3
$163K Sell
2,089
-500
-19% -$36.3K 0.05% 148
2016
Q2
$178K Hold
2,589
0.06% 133
2016
Q1
$185K Buy
+2,589
New +$163K 0.08% 112
2015
Q4
Sell
-1,500
Closed -$85K 625
2015
Q3
$85K Buy
+1,500
New +$79.4K 0.04% 150

Other funds holding CMD

Krilogy Financial's CMD Position: Q2 2018 in Review

Krilogy Financial sold out of Cantel Medical Corporation (CMD) in Q2 2018, closing a stake of 1,678 shares — an estimated $187K sold.

Krilogy Financial first reported a position in CMD in Q3 2015 and held it in 10 quarters. The position peaked at $329K in Q3 2017. 292 funds tracked by Wall St. Rank hold CMD as of Q2 2018.

  • Krilogy Financial reported no remaining Cantel Medical Corporation position as of Q2 2018 after selling out during the quarter.
  • Krilogy Financial sold 1,678 Cantel Medical Corporation shares in Q2 2018, an estimated $187K.
  • Krilogy Financial first reported a position in Cantel Medical Corporation in Q3 2015 and held it in 10 quarters.
  • Krilogy Financial's Cantel Medical Corporation position peaked at $329K in Q3 2017.
  • 292 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2018.

Based on Krilogy Financial's 13F filing for Q2 2018, filed 15 Aug 2018.